RecruitingNot ApplicableNCT04584632

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

A Clinical Evaluation of the Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery


Sponsor

Efemoral Medical, Inc.

Enrollment

100 participants

Start Date

Sep 22, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate the safety and performance of the EVSS in patients with symptomatic peripheral vascular disease from stenosis or occlusion of the femoropopliteal artery


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Efemoral Vascular Scaffold System (EVSS) for people with femoropopliteal stenosis, peripheral arterial disease, and other related conditions. The study is currently recruiting participants at 8 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEfemoral Vascular Scaffold System (EVSS)

Balloon-expandable, bioresorbable vascular scaffolds coated with sirolimus


Locations(8)

Northern Health

Sydney, New South Wales, Australia

Canberra Hospital

Canberra, Australia

The Alfred Hospital

Melbourne, Australia

Prince Of Wales Hospital

Sydney, Australia

Royal North Shore

Sydney, Australia

Auckland City Hospital

Auckland, New Zealand

Christchurch Hospital

Christchurch, New Zealand

Waikato Hospital

Hamilton, New Zealand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04584632


Related Trials